Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Chemotherapy in Cell-free Human Papillomavirus Deoxyribonucleic Acid (cfHPV-DNA) Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer (CC)

NCT05764044 is registered in ClinicalTrials.gov with Hospital do Coracao as lead sponsor.

NCT NCT05764044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05764044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Chemotherapy in Cell-free Human Papillomavirus Deoxyribonucleic Acid (cfHPV-DNA) Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer (CC)
Lead sponsor
Hospital do Coracao
Phase
Phase 3
Overall status
Recruiting
Start date
March 27, 2024
Completion date
December 31, 2026
Enrollment
365 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, cervix cancer, cervix neoplasm